Oncology Patients Clinical Trial
Official title:
An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown
In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.
Protocol No: Onco_Covid-19
Version no:1.0
Objectives: Firstly the patients recently diagnosed with cancer will be selected for
enrollment who are on active treatment during lockdown based on the date of their
registration in the hospital. This is followed by a telephonic interview with patients or
their attendant to carry out a prospective, cross-sectional, observational study in order to
address the issues and challenges faced by them during Lockdown.
Collection of data will be done through telephonic communication. Participation in this study
will be entirely voluntary. Telephonic verbal consent will be taken from the patients or
their attendants before collection of their response on the study questionnaire and then will
be asked questions accordingly based on the questionnaire which is available in English and
Hindi both. Data and general information regarding participants will only be collected in
questionnaire. No personal data of the participants will be taken which will also be conveyed
to the participant or attendant during telephonic verbal consent.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01444404 -
A Study of AMG 820 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT01253707 -
A Study of AMG 337 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT01723020 -
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
|
Phase 1 | |
| Completed |
NCT00813384 -
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT02110355 -
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
|
Phase 1 | |
| Terminated |
NCT02437916 -
Safety Study of AMG 228 to Treat Solid Tumors
|
Phase 1 | |
| Terminated |
NCT01231347 -
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
|
Phase 3 | |
| Completed |
NCT01300026 -
AMG 319 Lymphoid Malignancy FIH
|
Phase 1 | |
| Completed |
NCT02016729 -
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
|
Phase 1 |